IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Sex Hormone-Binding Globulin

Sex Hormone-Binding Globulin

Sex hormone-binding globulin (SHBG) is a glycoprotein that binds to sex hormones, specifically testosterone and estradiol. These sex hormones circulate in the bloodstream bound mostly to SHBG and, to some degree, albumin. Only a small fraction is unbound, or "free," and thus biologically active and able to enter a cell to activate its receptor. Bioavailability of sex hormones is influenced by the level of SHBG in this manner. SHBG levels are controlled by a delicate balance of enhancing and inhibiting factors. Its level is decreased by high levels of insulin and insulin-like growth factor-I (IGF-I). Also, high androgen levels decrease SHBG, while high estrogen and thyroxine levels increase it. Conditions with low SHBG include polycystic ovary syndrome, diabetes, and hypothyroidism. Conditions with high SHBG include pregnancy, hyperthyroidism, and anorexia nervosa.

Swiss-Prot Accession Number: P04278


Bibliography

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimers disease (2019) Wu W, Su BJ, Shen XN, Bi YL, Tan CC, Li JQ, Dong Q, Tan L, Alzheimers Disease Neuroimaging Initiative, Yu JT Cognitive Neuroscience

medical_services Therapy Indications

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial (2018) Wang A, Arver S, Boman K, Gerstein HC, Fu Lee S, Hess S, Ryden L, Mellbin LG Preventive Cardiology

medical_services Therapy Indications

Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3? signaling in bipolar patients (2013) Haenisch F, Alsaif M, Guest PC, Rahmoune H, Dickerson F, Yolken R, Bahn S Journal of Affective Disorders

medical_services Therapy Indications

Associations between gonadotropins, testosterone and ? amyloid in men at risk of Alzheimers disease (2012) Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, Martins RN Mol Psychiatry. 2012 Oct 23

medical_services Therapy Indications